Recently , we showed that liraglutide treatment in overweight individuals with prediabetes ( impaired fasting glucose and/or impaired glucose tolerance ) led to greater weight loss ( -7.7 % vs -3.9 % ) and improvement in insulin resistance compared with placebo .